EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
4.1.1.53 | Ataxia |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application unassigned |
1 0 |
4.1.1.53 | Carcinogenesis |
24467211 |
Glycine decarboxylase is an unusual amino acid decarboxylase involved in tumorigenesis. |
causal interaction unassigned |
3 0 |
4.1.1.53 | Carcinoid Tumor |
13928592 |
[Amino acid decarboxylase in pheochromocytoma and carcinoid tissue.] |
causal interaction ongoing research unassigned |
1 2 0 |
4.1.1.53 | Cerebral Palsy |
1078720 |
Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. |
diagnostic usage therapeutic application unassigned |
3 1 0 |
4.1.1.53 | Dyskinesias |
159153 |
[Serum dopamine-beta-hydroxylase, glutamic acid decarboxylase and 1-aromatic amino acid decarboxylase in involuntary movement disorders (author's transl)] |
diagnostic usage unassigned |
1 0 |
4.1.1.53 | Dystonia |
25597765 |
Syndromic intellectual disability: A new phenotype caused by an aromatic amino acid decarboxylase gene (DDC) variant. |
causal interaction unassigned |
3 0 |
4.1.1.53 | Dystonia |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application unassigned |
1 0 |
4.1.1.53 | Huntington Disease |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application unassigned |
1 0 |
4.1.1.53 | Hypotension, Orthostatic |
18368303 |
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience. |
therapeutic application unassigned |
1 0 |
4.1.1.53 | Hypothyroidism |
7389157 |
TSH and prolactin stimulation by the decarboxylase inhibitor benserazide in primary hypothyroidism. |
diagnostic usage ongoing research therapeutic application unassigned |
3 1 2 0 |